Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GANX
GANX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GANX News
Biotech Companies Targeting Parkinson's Disease
May 05 2026
Yahoo Finance
Gain Therapeutics to Present Updates on Parkinson's Disease Candidate GT-02287
Apr 24 2026
NASDAQ.COM
Gain Therapeutics Updates on GT-02287 for Parkinson's Disease
Apr 24 2026
Newsfilter
Gain Therapeutics Reports FY EPS Beat
Mar 26 2026
seekingalpha
GAIN THERAPEUTICS INC Reports $20.2 Million Net Loss for 2025, Equivalent to $0.61 Per Share
Mar 26 2026
moomoo
Gain Therapeutics Attends J.P. Morgan Healthcare Conference to Showcase GT-02287
Jan 07 2026
Globenewswire
GH Research PLC Shares Surge 18.1% on FDA IND Status Update Announcement
Jan 05 2026
Benzinga
Gain Therapeutics Hosts KOL Event on Parkinson's Disease Biomarkers and GT-02287
Dec 18 2025
Globenewswire
Gain Therapeutics Hosts KOL Event on Parkinson's Disease Biomarkers and GT-02287
Dec 18 2025
Newsfilter
Gain Therapeutics Demonstrates GT-02287's Positive Impact on Parkinson's Disease for the First Time
Dec 18 2025
Newsfilter
Reasons to Consider Gain Therapeutics, Inc. (GANX) as a Strong Momentum Stock Investment
Dec 08 2025
NASDAQ.COM
Gain Therapeutics (GANX) Receives Upgrade to Buy: Key Information You Need to Know
Nov 17 2025
NASDAQ.COM
Gain Therapeutics Reports GAAP EPS of -$0.15, Exceeding Expectations by $0.01
Nov 12 2025
SeekingAlpha
Gain Therapeutics to Hold Virtual KOL Event Focused on GT-02287 for Parkinson's Disease
Oct 09 2025
Newsfilter
Gain Therapeutics to Take Part in the 2025 Drug Discovery Innovation Program
Sep 23 2025
Newsfilter
Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference
Jul 24 2025
Newsfilter
Show More News
